Aetna will now reimburse for iRhythm's ZIO Patch, a continuous long-term heart monitor worn on an adhesive patch. The insurer recently updated its Clinical Policy Bulletin on cardiac event monitors, ...
The market has left medical device stocks in the dust, but heart monitor maker iRhythm Technologies is proving an exception. As doctors and hospitals slap its Zio patch monitors on more patients, the ...
Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed ...
Heart disease, particularly conditions like atrial fibrillation (AFib), is a leading cause of death worldwide, and traditional cardiac monitoring methods often present challenges in patient comfort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results